HIF2 Drives Kawasaki-Like Coronary Vasculitis
A longstanding mystery in Kawasaki disease (KD) is why some children develop catastrophic coronary artery aneurysms, thrombosis, and sudden cardiac death despite resolution of acute inflammation.
A new Circulation study identifies HIF2α as a potential master regulator of this process. Using a novel vascular-specific genetic model, investigators show that chronic activation of HIF2 signaling is sufficient to trigger coronary remodeling, aneurysm formation, thrombosis, calcification, and lethal vascular rupture—closely recapitulating severe KD.
The team deleted Vhl, the major negative regulator of hypoxia-inducible factors, in Wt1-lineage coronary vascular cells and cardiac fibroblasts.
The result was dramatic:
✅ Progressive coronary artery dilation
✅ Coronary arteritis
✅ Elastin fragmentation
✅ Smooth muscle cell loss
✅ Intracoronary thrombosis
✅ Perivascular fibrosis
✅ Vascular calcification
✅ Sudden death between 15–20 weeks of age
Importantly, systolic function remained largely preserved.
The primary pathology was vascular—not myocardial failure.
Mechanistically, HIF2 activation rewired multiple pathogenic programs simultaneously.
Transcriptomic analyses revealed activation of:
• Extracellular matrix remodeling
• TGF-β signaling
• Angiogenesis pathways
• Coagulation programs
• Inflammatory networks
• Osteogenic/calcification pathways
Key mediators included:
↑ MMP2
↑ MMP9
↑ TIMP1
↑ PAI-1
↑ Periostin (POSTN)
↑ Fibronectin (FN1)
↑ BMP2
↑ Osteoprotegerin (OPG)
These changes promoted elastin breakdown, arterial wall instability, thrombosis, and progressive aneurysmal remodeling.
A particularly striking observation was the inflammatory phenotype.
Affected coronary arteries accumulated:
• CD68⁺ macrophages
• MRP14⁺ neutrophils
• MPO-rich inflammatory infiltrates
• Increased IL-1β
• Increased MCP-1/CCL2
• Increased CXCL1
The pathology strongly resembled human coronary vasculitis.
Human validation
The authors analyzed fatal KD autopsy specimens.
Coronary aneurysm lesions demonstrated:
🔥 Strong HIF2α expression
in:
• Coronary media
• Coronary intima
• Perivascular inflammatory infiltrates
• Macrophage-rich regions surrounding aneurysms
In contrast, HIF1α expression was minimal or absent.
This suggests that HIF2—not HIF1—may be the dominant hypoxia pathway driving coronary vascular injury in severe KD.
The decisive experiment
When investigators genetically removed Hif2a from the Vhl-deficient mice:
✓ Coronary dilation disappeared
✓ Thrombosis resolved
✓ Fibrosis normalized
✓ Inflammation vanished
✓ Cardiomegaly reversed
✓ Transcriptomic abnormalities largely returned to baseline
Only seven genes remained differentially expressed versus controls.
The disease phenotype essentially collapsed.
Why this matters
Current KD research focuses heavily on IL-1β, TNFα, and innate immunity.
This study introduces a complementary framework:
Hypoxia signaling may sit upstream of vascular remodeling, thrombosis, and aneurysm progression.
HIF2 activation appears capable of integrating:
• Inflammation
• Matrix destruction
• VSMC loss
• Thrombosis
• Calcification
into a single disease-driving program.
Because selective HIF2 inhibitors already exist clinically, the findings raise the possibility that HIF2-targeted therapy could eventually become a strategy for preventing coronary complications in severe Kawasaki disease and related vasculitides.
Reference
Escobar B, Menendez-Montes I, Albendea-Gomez T, et al. Activation of HIF2 in Cardiac Vasculature Leads to Arterial Remodeling, Dilation, Thrombosis, and Inflammation, Recapitulating Cardiac Involvement in Kawasaki Disease. Circulation. 2026. DOI: 10.1161/CIRCULATIONAHA.125.076230.
#KawasakiDisease #HIF2 #CoronaryAneurysm #Vasculitis #CardioImmunology #VascularBiology #Hypoxia #Inflammation #Circulation #CardiovascularResearch